Figure 2.

Percentage of proliferation inhibition induced on WEHI-3 leukemia cells with the IC₂₅ or IC₅₀ of sodium caseinate (SC), cytarabine, or daunorubicin alone or in combination. PBS (A), SC IC₅₀ (B), cytarabine IC₅₀ (C), daunorubicin IC₅₀ (D), SC IC₂₅ (E), cytarabine IC₂₅ (F), daunorubicin IC₂₅ (G), SC : cytarabine IC₂₅:IC₂₅ (H), SC : daunorubicin IC₂₅ : IC₂₅ (I), cytarabine : daunorubicin IC₂₅ : IC₂₅ (J). Values are mean ± SD for three different independent experiments.  ^∗p ≤ 0.001 with the Tukey test, group I (B, C, and D column), group II (E, F, and G columns), and group III (H, I, and J columns) are different with respect to control (A column) and different from each other.